Perth biotech Syngenis is using AI to slash the time and cost of discovering RNA therapies, targeting a booming global market ...

Authored by Ram Ramprasad, Sustainablity Expert Years ago, I wrote in The Elephant Journal about our family cow — how she found her way back to us in Hyderabad after being sold, navigating streets and ...

Biotech compliance overhaul: Venkatesh Kanneganti modernized validation systems at Gilead Sciences, streamlining processes and integrating automation to meet evolving global standards. AI governance ...

Announced strategic collaboration with Mayo Clinic, focused on improving care in type 1 diabetes and accelerating development of SC451Continued ...

FDA drug approvals are reshaping biotech stocks—track key decisions, FDA leadership turmoil, and volatility. Click for a look ...

In addition, ABS-1230 for the treatment of KCNT1-related epilepsy has been accepted into the FDA’s Rare Disease Evidence Principles (RDEP) process, a framework designed to facilitate development of ...

Dublin, April 29, 2026 (GLOBE NEWSWIRE)-- The "Technical Writing for Med Devices, Pharma and Biotech (July 20th - July 23rd, 2026)" training has been added to ResearchAndMarkets.com's offering. This 4 ...

CellProthera will use Quintessence’s DACSTM flotation‑based cell sorting platform for its potential to enhance therapeutic purity and preserve stem cell phenotype for CD34+-based cell therapy Mulhouse ...

Following its recently announced partnership with Novo Nordisk, OpenAI is introducing a new reasoning model, GPT-Rosalind, to support research in biology, drug discovery and translational medicine.

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

Anthropic has purchased the stealth biotech AI startup Coefficient Bio in a $400 million stock deal, according to The Information and Eric Newcomer. Sources close to the deal confirmed to TechCrunch ...

State Street SPDR S&P Biotech ETF (XBI) gained +40.32% over the past year and equally weights roughly 145 stocks to provide exposure to smaller biotech companies. iShares Biotechnology ETF (IBB) ...